Table 2.
Characteristics | Total(N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Odds Ratio (95% CI) | P-value | Odds Ratio (95% CI) | P-value | ||
Sex | 3301 | ||||
Female | 1074 | Reference | |||
Male | 2227 | 1.150 (0.945–1.400) | 0.163 | ||
Age | 3301 | ||||
< 60 | 1698 | Reference | Reference | ||
≥ 60 | 1603 | 1.738 (1.446–2.089) | < 0.001 | 1.600 (1.220–2.100) | 0.001 |
aCCI | 3301 | 1.200 (1.145–1.258) | < 0.001 | 1.038 (0.948–1.136) | 0.423 |
SOFA | 3301 | 1.151 (1.117–1.185) | < 0.001 | 1.076 (1.029–1.125) | 0.001 |
MAP, mmHg | 3301 | 0.983 (0.978–0.987) | < 0.001 | 0.995 (0.989–1.001) | 0.095 |
FIO2 | 3301 | 0.997 (0.990–1.005) | 0.517 | ||
PCO2, mmHg | 3301 | 0.957 (0.947–0.968) | < 0.001 | 0.968 (0.955–0.982) | < 0.001 |
PO2, mmHg | 3301 | 0.996 (0.989–1.002) | 0.164 | ||
WBC, 1012/L | 3301 | 1.005 (0.999–1.011) | 0.119 | ||
PLT, 109/L | 3301 | 0.998 (0.997–0.999) | < 0.001 | 1.001 (0.999–1.002) | 0.333 |
Lac, mmol/L | 3301 | 1.203 (1.140–1.270) | < 0.001 | 1.250 (1.138–1.374) | < 0.001 |
APTT, S | 3301 | 1.024 (1.013–1.035) | < 0.001 | 1.002 (0.990–1.014) | 0.762 |
Urine, mL | 3283 | 1.000 (1.000–1.000) | 0.433 | ||
ALT, U/L | 3301 | 1.001 (1.000–1.001) | 0.016 | 1.000 (0.999–1.001) | 0.691 |
AST, U/L | 3301 | 1.000 (1.000–1.001) | 0.021 | 0.999 (0.999–1.000) | 0.003 |
BUN, mmol/L | 3301 | 1.021 (1.008–1.035) | 0.002 | 0.959 (0.933–0.985) | 0.002 |
Cr, µmol/L | 3301 | 1.001 (1.000–1.001) | 0.029 | 1.001 (1.000–1.002) | 0.073 |
BMI, kg/m2 | 3301 | 0.902 (0.876–0.928) | < 0.001 | 0.899 (0.873–0.925) | < 0.001 |
Congestive Heart Failure | 2542 | 1.162 (0.932–1.450) | 0.183 | ||
Renal failure | 968 | 1.468 (1.213–1.776) | < 0.001 | 1.090 (0.864–1.376) | 0.466 |
Hepatic failure | 164 | 2.026 (1.426–2.879) | < 0.001 | 1.454 (0.990–2.135) | 0.056 |
Tumor | 754 | 1.171 (0.948–1.445) | 0.143 | ||
Sepsis | 3126 | 1.320 (0.849–2.050) | 0.217 | ||
ARDS | 2845 | 1.060 (0.8121–1.382) | 0.670 |
Bold indicates statistically significant P values